Conferences

BIO Asia–Taiwan 2026 will be held July 15-19 at the TaiNEX 1 & 2 halls, Nangang Exhibition Center, Taipei. The event brings together bioindustry executives and investors from North America, Europe and Asia to explore business opportunities and to engage with Taiwan's growing biotech sector. The five-day gathering includes a three-day conference featuring 250+ internationally-renowned speakers, company presentations from Asia and around the world, BIO Partnering™ meetings, a full program of symposia and workshops, and an international exhibition.

Delegates from Venture Valuation and Biotechgate will attend the event.

Now in its fourth year, Asia Bio Partnering Forum will unite over 650 innovators from major Asian markets with global life science leaders to foster dealmaking and collaboration across the region.

Delegates from Venture Valuation and Biotechgate will attend the event.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Delegates from Venture Valuation and Biotechgate will attend the event.

The 12th Annual BioHealth Capital Region Week returns September 15–17, 2026, at US Pharmacopeia in Rockville, Maryland, bringing together leaders from industry, academia, government, investment, and entrepreneurship for three days of programming, networking, and regional collaboration. This year’s theme, “Growing the BioHealth Capital Region of Tomorrow,” reflects the work needed now to strengthen commercialization, expand access to capital, build new partnerships, and support the next generation of biohealth companies. As organizations across the ecosystem navigate a more uncertain funding environment, BHCR Week provides a place for the region to come together around shared priorities and future growth. The week includes the BioHealth Capital Region Forum, the Crab Trap Competition, and the BioHealth Capital Region Investment Conference.

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions

Delegates from Venture Valuation and Biotechgate will attend the event.

LSX Congress USA in Boston is where biotech companies at different stages of growth come to meet the investors and pharma partners who can help shape what comes next. From emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum, the event is built around the conversations that matter most. Get a 15% discount to LSX Congress USA when signing up by using the promo code: VV15. Register here »

A global, multi-time zone online Forum offers an essential half-day of insight and debate for those working at the intersection of drug discovery, innovation and investment.

BIOSPAIN is one of the largest biotech events organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 30% of our delegates came from outside of Spain. Also, of the 287 exhibitors, 32% were international. This year, BIOSPAIN will be held in Bilbao, one of the main biotech cluster in Spain and One of Spain’s most avant-garde cities. The event will take place in Pavillion 2, Bilbao Exhibition Cente, located in Barakaldo, less then 20 minutes from downtown Bilbao, it is one of the most modern and largest trade-show complexes in Europe.

Delegates from Venture Valuation and Biotechgate will attend the event.

Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech and healthtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 19 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. The conference has a broad focus within biotech, healthtech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial

Delegates from Venture Valuation and Biotechgate will attend the event.

Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

Delegates from Venture Valuation and Biotechgate will attend the event.

BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.

Delegates from Venture Valuation and Biotechgate will attend the event.

Through expert-led discussions and networking, attendees will gain insights into the impact of AI and emerging technologies, access to early-stage capital, regulatory developments, and the strategies and partnerships needed to accelerate the path from discovery to patient impact.

BIO-Europe, Europe's premier biopharma partnering event, is heading to Cologne, Germany on November 9-11, 2026.

Delegates from Venture Valuation and Biotechgate will attend the event.

Set in one of Europe's leading life sciences hubs, the Basel conference explores how drug discovery can scale through advanced technologies, European investment, strategic partnerships, and cross-border collaboration.